Swiss – Brompton Cardio-Oncology Summit

We are pleased to announce that the third edition of the Swiss-Brompton Cardio-Oncology Summit will take place from March 5–6, 2026 in the German-speaking region of Switzerland. The exact venue will be announced soon — in the meantime, book your tickets to Zurich!

The first edition in February 2024 was a great success, made possible thanks to our partnerships with many sponsors. The second edition is scheduled for February 13–14, 2025.

The 2026 summit will be an international and educational gathering with a strong focus on cardio-oncology, and will cover the following main topics:

breast cancer, lung cancer, melanoma, cardiac amyloidosis, and the latest advances in cardio-oncology.

The target audience includes cardiologists, hematologists, oncologists, and internists.

In collaboration with the Swiss Amyloidosis Network (SAN), co-organizer of the event, one of the main topics will be new trends in the diagnosis and treatment of systemic amyloidosis. Building on the highly successful seminar at this year's Annual Meeting of the Swiss Society of Cardiology in Lausanne, we are excited to welcome Prof. Rodney Falk from Brigham and Women’s Hospital, Boston, and Prof. Ronald Witteles from Stanford University, who will deliver keynote lectures on cardiac amyloidosis, followed by highly interactive discussions.

In addition to amyloidosis, other major topics will include cardio-oncology-specific issues such as cardiac dysfunction and heart failure during cancer therapies, optimization of cardiovascular risk factors during and after oncological treatments, hematopoietic stem cell transplantation, CAR-T cell therapy, lymphomas, sarcomas, and updates on cancer treatments.

This third edition of the Swiss-Brompton Cardio-Oncology Summit is expected to once again bring together over 100 in-person participants, including cardiologists, oncologists, hematologists, and internists.